Research & Development World

  • Home Page
  • Topics
    • Aerospace
    • Archeology
    • Automotive
    • Biotech
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Market Pulse
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Battery Technology
    • Imaging
    • Nanotechnology
    • Semiconductors
  • Controlled Environments
    • Cleanrooms
    • Graphene
    • Lasers
    • Regulations/Standards
    • Sensors
  • Scientific Computing
    • Big Data
    • HPC/Supercomputing
    • Informatics
    • Security
    • Software
  • R&D 100 Awards
    • ENTER NOW
    • 2020 Winners
    • Winner Archive
    • R&D 100 Conference
  • Resources
    • Digital Issues
    • Podcasts
    • Subscribe
  • 2021 Funding Forecast
  • COVID-19

R&D Market Pulse: Stats Point to Continued U.S. Economic Growth

By Tim Studt | June 17, 2019

The R&D Index for the week ending June 14, 2019 closed at 4,580.03 for the 25 companies in the R&D Index. The Index was up 1.91% (or 85.68 basis points) from the week ending June 7, 2019. Eighteen of the 25 R&D Index members gained value from 0.04% (Oracle and Qualcomm) to 3.64% (Amazon). Seven of the 25 R&D Index members lost value last week from -0.37% (Pfizer) to -5.59% (Eli Lilly Company).

The Labor Department announced last Wednesday that the Consumer Price Index (CPI) rose 0.1% in May from April and 1.8% from May 2018, less than the expected 1.9%. This was weaker than the 0.3% increase in April from March and also weaker than April’s 2.0% increase from April 2018. The lower interest rates were touted as being responsible for a 27% surge in mortgage applications during the first week in June.

The Federal Reserve was concerned about a slowing economy over the past two months and had been considering a rate cut which could be put in place at its regular meeting this week on June 19. However, the Commerce Department reported on Friday that retail sales rose 0.5% in May from April muting the need for an interest rate cut at this point in time. The Fed also reported on Friday that manufacturing output rose 0.2% in May, following a 0.5% decline in April and the first actual increase in 2019.

Aerospace firms Raytheon and United Technologies stated last week that they planned to merge by the end of 2019. The firms cited their combined R&D spending of about $8 billion as one of the primary reasons for the merger so that they could more effectively compete with the likes of Boeing and Lockheed Martin’s R&D investments. Boeing and LM each invest between $2 and $3 billion annually in R&D.

South Korea’s leading mobile telecom company, SK Telecom, announced last week that it has signed memoranda of understanding (MOU) with Finland’s Nokia and Sweden’s Ericsson to step up collaboration and R&D technologies related to 6G networks. SK Telecom rolled out its 5G commercial networks in April. 6G networks are expected to integrate satellites for global coverage with first commercial development not expected until 2030. China announced earlier this year that it was working on 6G development.

The U.S. Department of Energy last week announced that it was banning its researchers from joining Chinese talent recruitment programs in an effort to stave off China’s pervasive theft of U.S. science and technology assets.

R&D Index Week Ending June 14, 2019
Ticker Exchange 2018 R&D millions U.S. $ 06/07/19 06/14/19 6/14/19 to 6/7/19 6/14/19 to 12.31.18
1 Amazon AMZN NASDAQ 26,750 1,804.03 1,869.67 3.64% 24.48%
2 Alphabet/Google GOOGL NASDAQ 18,796 1,068.37 1,086.30 1.68% 3.96%
3 Apple AAPL NASDAQ 14,037 190.15 192.74 1.36% 22.19%
4 Intel INTC NASDAQ 13,702 46.03 46.19 0.35% -1.58%
5 Microsoft MSFT NASDAQ 13,558 131.40 132.45 0.80% 30.40%
6 Roche Pharm RHHBY OTC 12,284 34.24 34.55 0.91% 11.16%
7 Johnson & Johnson JNJ NYSE 11,493 138.55 140.09 1.11% 8.55%
8 Merck & Co. MRK NYSE 11,323 82.46 82.78 0.39% 8.34%
9 Volkswagen AG VWAGY OTC 10,915 16.37 16.11 1.61% 3.27%
10 Toyota TM NYSE 10,848 122.39 124.39 1.63% 7.16%
11 Novartis NVS NYSE 8,934 88.06 89.52 1.66% 4.32%
12 Honda HMC NYSE 8,180 25.58 25.34 -0.94% -4.20%
13 Pfizer PFE NYSE 7,942 42.92 42.76 -0.37% -2.04%
14 Daimler DDAIY OTC 7,615 54.01 53.19 -1.52% 0.80%
15 General Motors GM NYSE 7,278 35.49 35.66 0.48% 6.61%
16 Oracle ORCL NYSE 7,001 53.26 53.28 0.04% 18.01%
17 Bristol-Myers Squibb BMY NYSE 6,981 46.75 47.56 1.73% -8.50%
18 Eli Lilly Co LLY NYSE 6,769 118.35 111.74 -5.59% -3.44%
19 GlaxoSmithKline GSK NYSE 6,394 39.80 40.12 0.80% 5.00%
20 Cisco CSCO NASDAQ 6,009 55.93 54.75 -2.11% 26.36%
21 IBM IBM NYSE 5,842 133.31 135.15 1.38% 18.90%
22 Bayer AG BAYN OTC 5,743 14.98 14.83 -1.00% -15.59%
23 Astra Zeneca PLC AZN NYSE 5,483 39.02 39.67 1.67% 4.45%
24 Qualcomm QCOM NASDAQ 5,183 68.69 68.72 0.04% 20.77%
25 Sanofi SA SNY NYSE 4,694 44.21 42.47 -3.94% -2.17%
Total 243,754 4,494.35 4,580.03 1.91% 13.72%
Biopharmaceutical 689.34 686.09 -0.47% 2.27%
Automotive 253.84 254.69 0.33% 4.23%
ICT 1,747.14 1,769.58 1.28% 9.89%

 

About the R&D Index

R&D Magazine's R&D Index is a weekly stock market summary of the top international companies involved in research and development. The top 25 industrial spenders of R&D in 2017 were selected based on the latest listings from Schonfeld & Associates' June 2018 R&D Ratios & Budgets. These 25 companies include pharmaceutical (11 companies), automotive (5), ICT (8) and conglomerate (1) organizations who invested a cumulative total of more than $209 billion in R&D in 2017, or approximately 10% of all the R&D spent in the world by government, industries and academia combined, according to R&D Magazine's 2019 Global R&D Funding Forecast. The stock prices used in the R&D Index are tabulated from NASDAQ, NYSE, XETRA and OTC common stock prices (in U.S. dollars) for the companies selected at the close of stock trading business on the Friday preceding the publication of the R&D Index in R&D Magazine's R&D Daily eNewsletter.

Related Articles Read More >

R&D World Index: Honda’s R&D head promoted to CEO
R&D World Index: Increased R&D making more EV models available in 2021
R&D World Index: R&D firms forming collaborations
R&D 100 winner Horizon Therapeutics to acquire Viela Bio to expand development and grow rare disease medicine portfolio

Need R&D World news in a minute?

We Deliver!
R&D World Enewsletters get you caught up on all the mission critical news you need in research and development. Sign up today.
Enews Signup
Tweets by @RandDWorld

R&D World Digital Issues

February 2020 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R& magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • 2021 Global Funding Forecast

Copyright © 2021 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • Home Page
  • Topics
    • Aerospace
    • Archeology
    • Automotive
    • Biotech
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Market Pulse
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Battery Technology
    • Imaging
    • Nanotechnology
    • Semiconductors
  • Controlled Environments
    • Cleanrooms
    • Graphene
    • Lasers
    • Regulations/Standards
    • Sensors
  • Scientific Computing
    • Big Data
    • HPC/Supercomputing
    • Informatics
    • Security
    • Software
  • R&D 100 Awards
    • ENTER NOW
    • 2020 Winners
    • Winner Archive
    • R&D 100 Conference
  • Resources
    • Digital Issues
    • Podcasts
    • Subscribe
  • 2021 Funding Forecast
  • COVID-19